Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
2.710
-0.380 (-12.30%)
At close: Jan 21, 2025, 4:00 PM
3.120
+0.410 (15.13%)
Pre-market: Jan 22, 2025, 5:13 AM EST
Evaxion Biotech Market Cap
Evaxion Biotech has a market cap or net worth of $3.18 million as of January 22, 2025. Its market cap has decreased by -88.64% in one year.
Market Cap
3.18M
Enterprise Value
-1.40M
1-Year Change
-88.64%
Ranking
Category
Stock Price
$2.71
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion Biotech's market cap has decreased from $191.99M to $3.18M, a decrease of -98.34%. That is a compound annual growth rate of -64.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 3.63M | -26.90% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |